Rifampin-Resistant <em>Cutibacterium</em> (formerly <em>Propionibacterium</em>) <em>namnetense</em> Superinfection after <em>Staphylococcus aureus</em> Bone Infection Treatment

Abstract

After rifampin and levofloxacin treatment for a Staphylococcus aureus bone infection, a pyogenic granuloma due to a newly described Cutibacterium species, C. namnetense developed on the tibia former external fixator. This rifampin resistant bacterium, selected during treatment, harbored a mutation in the rpoB gene. This case illustrates the possible in vivo selection of resistant mutant most likely due to the bacterial burden and therefore the importance of adequate bone infection treatment.